16th Annual ENETS Conference: Speakers' Updates, Scientific Programme, Grant Winners and Abstract Submissions
The 16th Annual ENETS Conference and the 9th Annual ENETS Postgraduate Course have been accredited with 18 CME points by the UEMS - EACCME®! The scientific programme is available online and we would like to draw your attention to some of the highlights awaiting you this year!
Please note that the regular registration fee ends 11 February 2019.
ENETS would like to congratulate all our grant winners for 2019. This year, we were inundated with many fantastic grant applications of the highest quality. ENETS is proud to award three ENETS CoE Synergy Grants, one ENETS Translational Medicine Fellowship, two CoE Training Fellowships and eleven Travel Grants! We would like to say a big thank you to all those who applied this year. For those of you not selected for a grant this year, we look forward to seeing your applications next year. Click on the button below to keep yourself up-to-date on all ENETS grant news.
Once again, the abstracts submitted were of very high quality, and the abstract reviewing committee approved almost all of them for poster presentation. Poster presentations enable all authors to portray their research work to a large audience during the three-day conference. If you would like to know more about our poster and e-poster guidelines as well as our poster templates, please click on the button below.
ENETS is delighted to host an international and renowned faculty for its 16th Annual ENETS Conference. Here is our second instalment – please read about the speakers and their talks here and in the upcoming conference updates.
Highlight: Session 3 – ENETS European Society of Pathology (ESP): New Classification / Making Sense of High-grade Neoplasms.
ENETS is hosting this year’s collaborative session with the European Society of Pathology (ESP). We warmly welcome our ESP colleagues and hope to explore the therapeutic consequences of high-grade neoplasms.
Aurel Perren is Professor of Pathology at the University Bern in Switzerland. He will talk about the new WHO classification and other important news during session 3 on Thursday, 7 March, from 10:45 – 11:05.
Jean-Yves Scoazec is Professor of Pathology at Université Paris Sud and Head of the Department of Pathology and Laboratory Medicine in Gustave Roussy Institute, Villejuif, France, where he is also Director of the “Molecular Analysis, Imaging and Modelling of Cancer” Research Unit. He will talk about pulmonary and digestive high-grade NENs (and how they are similar) during session 3 on Thursday, 7 March, from 11:05 – 11:25.
Halfdan Sorbye is Professor and Head of NET and GI section at Department of Oncology, Haukeland University Hospital in Bergen, Norway. He is leading the retrospective and prospective Nordic NEC trial. He will talk about the treatment of high-grade NEN and the consequences implicated by the new classification of high-grade NEN during session 3 on Thursday, 7 March, from 11:25 – 11:45.
Highlight: Session 4 – Surgical Controversies
Alain Sauvanet is Associate Professor of Surgery in the Department of HPB Surgery of Hospital Beaujon and Chair of the Pole of Digestive Diseases for the University Denis Diderot in Paris, France. He will talk about surgery for progressive oligo-metastatic disease during session 4 on Thursday, 7 March, from 12:00 – 12:15.
Andreas Pascher is Professor of Surgery at the University of Muenster (UKM) in Germany. He will talk about surgery for NET-G3/NEC and whether it is ever recommended during session 4 on Thursday, 7 March, from 12:15 – 12:30.